Live Webinar - Alzheimer’s Roadmap: Addressing the challenges for Improved Outcomes


We are organizing a webinar on “Alzheimer’s Roadmap: Addressing the challenges for improved outcomes,” which will primarily focus on the market scenario addressing the significant hurdles the pharmaceutical companies face and how they can be addressed. The webinar will be conducted on 6th June 2023 for Europe at 05:00 PM CEST and for the US at 8:00 AM PDT.

Alzheimer’s disease (AD) was not the most researched indication among pharma/biopharma companies until the US 2020 census declared that the prevalence of clinical AD could be 11.3%. As per the Alzheimer’s Association, more than 6 million people in the US are living with the indication, and over 11 million Americans are providing unpaid care for people with Alzheimer’s or other dementias. Between 2000 and 2019, the death rate from Alzheimer’s increased by 145%, with a projected healthcare cost of USD 345 Billion in 2023. Analysts also suggest that the cost could rise to nearly USD 1 Trillion.

This could be a huge burden to the US healthcare system, and the administration might have to deal with significant logistical and diagnostic challenges. Also, with reference to the decision-making for the drug, the diagnosis & detection rate is slower than other indications, which creates a huge gap in the market in prescribing the medication by physicians.

Speakers: Sibasish Dutta Choudhuri and Hitesh Gupta

This webinar will unfold the opportunities for various pharmaceutical or biopharmaceutical companies to fully understand the key challenges and advances for Alzheimer’s. What is the major challenge concerning the market, and why could only a few drugs make it to the market? Our speakers will thoroughly discuss the key aspects of competition and opportunities in the market. Besides this, there will also be a discussion on strategic approaches to be taken by pharmaceutical, health insurance, and physicians to help them mitigate the burden of the disease.

Limited Seats Available! Visit below link for more information. Register now@
https://www.iebrain.com/webinars/Alzheimers-Roadmap/

About Ingenious e-Brain Solutions: -

Ingenious e-Brain Solutions provides high-quality, customized, and cost-effective Technology Intelligence, Business Intelligence, and Intellectual Property Intelligence solutions to industry leaders, and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality results ensuring fool-proof confidentiality and security. We are an ISO certified company with offices in India and USA.

Ingenious e-Brain Solutions has a strong team of analysts, and subject matter experts with domain proficiency which is devoted to help clients grow. Our highly qualified professionals offer tailored, value-added and cost-effective services to our clients. We believe in building long term relationships with our clients who include national and international corporations, Fortune 500 companies, world’s leading research institutes and universities as well as independent inventors.

Get in Touch: -
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218

Email: -
queries@iebrain.com

Comments

Post a Comment

Popular posts from this blog

Medical Device Companies Can Meet The Increasing Demand For Improved Medical Equipment By Adopting IEBS-derived Strategic Solutions

Image
Overview: The biomedical industry, an evolving healthcare industry segment, can phenomenally revolutionize the healthcare device market. With the significant technological developments in surgical devices, implants, bioprinting, imaging methods, and much more, the biomedical industry is bridging the gap between biological science, medicine, and engineering. Potential Opportunities Across Biomedical Industry: In an era of value-based delivery model, patients are now opting for treatments with minimally invasive procedures, which minimizes in-patient hospital stay and reduces healing time, thus reducing overall healthcare expenditure. For performing surgeries with the least incisions, such as pacemaker implantation, angioplasty, or smart drug delivery devices integration, among others; highly sophisticated devices loaded with various sensors & camcorders are a mandate. Hence, a rapid increase in demand for such advanced medical equipment across multiple tertiary healthcare cent
Read more

How Is AI Optimizing Different Aspects of FDA Submissions?

Image
The Department of Health and Human Services Regulatory agency is known as The Food and Drug Administration. The FDA is accountable for protecting and promoting public health through controlling and supervising food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, and medical devices. FDA approval is a must for any drug to be on the market. FDA plays a crucial role in reviewing drugs, medical devices, and biologics before it enters the market. The development of pharmaceuticals is a complex and lengthy process. Companies abide by the regulatory body’s guidelines for the effectiveness of the drugs, vaccines, biologics, and medical devices, for which FDA submission is essential and crucial in several steps. Nowadays, companies are leveraging artificial intelligence for effective and quick submissions. The FDA is also developing a new regulatory framework to promote inno
Read more

Overcoming The Challenges of CAR T-Cell Therapy Development

Image
In today’s world, there is no scarier disease than cancer. Cancer is often considered deadly and untreatable, supported by the fact that cancer has been one of the crucial causes of mortality globally. In 2020, there were approximately 19.3 million new cancer cases and almost 10.0 million cancer deaths. However, with Medicine, Biotechnology, and the pharmaceutical industry advancing rapidly, it is safe to say that not all cancers are deadly and untreatable. It is possible to get rid of cancer if diagnosed at the right time with various new and emerging Immunotherapies. Immunotherapy is a treatment technique for cancer that aids your immune system in fighting cancerous cells. There are multiple types of Immunotherapies used for cancer treatment, such as: ·          Immune checkpoint inhibitors: This treatment involves drugs that can block the immune checkpoints, thereby allowing the immune systems to function fully activated and more potent than usual. ·          Monoclonal antibodi
Read more